Seeds of Doubt
The New Yorker’s Michael Specter picks up where David Rotman left off in our January cover story and challenges the opposition to genetically modified foods.
—Brian Bergstein, deputy editor
Delivery Start-Ups Are Back Like It’s 1999
An interesting piece about the business models, or lack thereof, behind the latest rash of product-delivery apps and services.
—Will Knight, news and analysis editor
The Ivy League, Mental Illness, and the Meaning of Life
A worthwhile read on some potential pitfalls of an elite education.
—Kyanna Sutton, senior Web producer
How Much Should You Know About How Facebook Works?
A coauthor of the Facebook study that attempted—successfully—to manipulate the emotions of users argues that it is impossible for people to expect informed consent about such experiments.
—Tom Simonite, senior editor, IT
Cities Are Making Spiders Grow Bigger and Multiply Faster
These spiders are living it up in Sydney, Australia.
—J. Juniper Friedman, associate Web producer
Look at What Two Years on Mars Did to the Curiosity Rover
I like the use of the image sliders that the Verge is experimenting with here.
Joyce Chen, director of communications, MIT enterprise forum global
Twitter: From Free Speech Champion to Selective Censor?
In the wake of the release of a horrific video from Iraq, Twitter once again blurred the line between platform and publisher.
—Mike Orcutt, research editor
A Place Beyond Words: The Literature of Alzheimer’s
How fiction writers struggle to capture the experience of dementia.
—Linda Lowenthal, copy chief
Arrogance Is Good: In Defense of Silicon Valley
Do you have to be an asshole to change the world?
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.